Discovery May Lead to Improvements in Treating Alzheimer's Disease
the Psychiatry Advisor take:
A new drug target to fight Alzheimer's disease might also be used as a diagnostic tool for the disease, according to researchers at Pennsylvania State University.
A team found that the GABA neurotransmitter was drastically increased in the deformed versions of the normally large, star-shaped "astrocyte" cells which,support individual neurons in the brain. High concentrations of that neurotransmitter is a novel biomarker that researchers hope can be further investigated a a diagnosis tool and for treatment.
Research behind many drugs in development for Alzheimer's targets the sticky buildup of the amyloid protein known as plaques, which can cause neurons in the brain to die.
Japanese Drugmaker Accelerates Development of Alzheimer's Drug
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation